These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1691217)

  • 1. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis.
    Davis LT; Duffy DM
    J Dermatol Surg Oncol; 1990 Apr; 16(4):327-30. PubMed ID: 1691217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy.
    Goldman MP; Fitzpatrick RE
    J Dermatol Surg Oncol; 1990 Apr; 16(4):338-44. PubMed ID: 2324370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment.
    Goldman MP; Sadick NS; Weiss RA
    Dermatol Surg; 1995 Jan; 21(1):19-29; quiz 31-2. PubMed ID: 7600016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compression in the treatment of leg telangiectasia: a preliminary report.
    Goldman MP; Beaudoing D; Marley W; Lopez L; Butie A
    J Dermatol Surg Oncol; 1990 Apr; 16(4):322-5. PubMed ID: 2324368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lasers in the treatment of leg veins.
    Kauvar AN
    Semin Cutan Med Surg; 2000 Dec; 19(4):245-52. PubMed ID: 11149605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telangiectasias associated with reticular veins. Sclerotherapy or combined sclerotherapeutic and surgical approach?].
    Albanese V; Cavallaro G
    Minerva Cardioangiol; 2002 Feb; 50(1):29-37. PubMed ID: 11830716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Apr; 16(4):333-6. PubMed ID: 2324369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptors: their role in postsclerotherapy angiogenesis telangiectatic matting (TM).
    Sadick NS; Urmacher C
    Dermatol Surg; 1999 Jul; 25(7):539-43. PubMed ID: 10469110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of lasers and light sources in the treatment of leg veins.
    Dover JS; Sadick NS; Goldman MP
    Dermatol Surg; 1999 Apr; 25(4):328-35; discussion 335-6. PubMed ID: 10417593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerotherapy for varicose and telangiectatic veins.
    Green D
    Am Fam Physician; 1992 Sep; 46(3):827-37. PubMed ID: 1514476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predisposing factors of varicose and telangiectatic leg veins.
    Sadick NS
    J Dermatol Surg Oncol; 1992 Oct; 18(10):883-6. PubMed ID: 1430543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial.
    Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of brimonidine tartrate to resolve telangiectatic matting: case report.
    de Mello BAS; Beiriz YR; Bonatto AC; Maciel GSB; de Almeida LR; Corassa JM
    J Vasc Bras; 2020; 19():e20190159. PubMed ID: 34290750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telangiectatic Matting is Associated with Hypersensitivity and a Bleeding Tendency.
    Kadam P; Lim J; Paver I; Connor DE; Parsi K
    Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):554-559. PubMed ID: 29409702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. My sclerotherapy technique for telangiectasia and reticular veins.
    Goldman MP
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1040-5. PubMed ID: 20590711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of serum ferritin levels and postsclerotherapy pigmentation. A prospective study.
    Thibault PK; Wlodarczyk J
    J Dermatol Surg Oncol; 1994 Oct; 20(10):684-6. PubMed ID: 7930015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines of care for sclerotherapy treatment of varicose and telangiectatic leg veins. American Academy of Dermatology.
    J Am Acad Dermatol; 1996 Mar; 34(3):523-8. PubMed ID: 8609276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.